BlackRock’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$202M Buy
26,346,443
+745,224
+3% +$5.1M ﹤0.01% 1665
2025
Q4
$50.7M Buy
25,601,219
+5,790,256
+29% +$13.1M ﹤0.01% 2506
2025
Q3
$48.7M Buy
19,810,963
+2,043,750
+12% +$5.26M ﹤0.01% 2519
2025
Q2
$46.9M Buy
17,767,213
+4,477,157
+34% +$12M ﹤0.01% 2486
2025
Q1
$40M Sell
13,290,056
-294,686
-2% -$893K ﹤0.01% 2491
2024
Q4
$34.8M Buy
13,584,742
+1,727,211
+15% +$7.2M ﹤0.01% 2689
2024
Q3
$44.1M Buy
11,857,531
+434,442
+4% +$2.01M ﹤0.01% 2544
2024
Q2
$72.2M Buy
11,423,089
+1,047,778
+10% +$6.91M ﹤0.01% 2221
2024
Q1
$55.7M Sell
10,375,311
-334,868
-3% -$1.52M ﹤0.01% 2378
2023
Q4
$53.8M Sell
10,710,179
-100,852
-0.9% -$316K ﹤0.01% 2430
2023
Q3
$18.3M Buy
10,811,031
+1,312,365
+14% +$2.64M ﹤0.01% 2990
2023
Q2
$26.4M Buy
9,498,666
+2,533,147
+36% +$7.16M ﹤0.01% 2865
2023
Q1
$12.7M Sell
6,965,519
-54,615
-0.8% -$170K ﹤0.01% 3194
2022
Q4
$35.6M Buy
7,020,134
+802,935
+13% +$4.41M ﹤0.01% 2697
2022
Q3
$30.9M Buy
6,217,199
+309,550
+5% +$1.41M ﹤0.01% 2775
2022
Q2
$22M Buy
5,907,649
+794,776
+16% +$3.19M ﹤0.01% 3038
2022
Q1
$28.7M Sell
5,112,873
-228,945
-4% -$1.4M ﹤0.01% 2940
2021
Q4
$32.5M Sell
5,341,818
-209,750
-4% -$1.58M ﹤0.01% 2969
2021
Q3
$54.1M Buy
5,551,568
+278,411
+5% +$3.06M ﹤0.01% 2610
2021
Q2
$75.3M Buy
5,273,157
+1,719,492
+48% +$28.4M ﹤0.01% 2428
2021
Q1
$84.4M Buy
3,553,665
+250,255
+8% +$6.49M ﹤0.01% 2278
2020
Q4
$44M Buy
3,303,410
+1,196,762
+57% +$11.5M ﹤0.01% 2558
2020
Q3
$14.6M Buy
2,106,648
+53,602
+3% +$534K ﹤0.01% 3044
2020
Q2
$25.2M Buy
2,053,046
+1,376,606
+204% +$7.77M ﹤0.01% 2680
2020
Q1
$1.95M Sell
676,440
-4,035
-0.6% -$20.2K ﹤0.01% 3665
2019
Q4
$2.58M Buy
680,475
+319,902
+89% +$544K ﹤0.01% 3709
2019
Q3
$440K Sell
360,573
-3,238
-0.9% -$4.02K ﹤0.01% 4201
2019
Q2
$371K Sell
363,811
-1,345,294
-79% -$1.55M ﹤0.01% 4243
2019
Q1
$2.7M Sell
1,709,105
-35,640
-2% -$44.8K ﹤0.01% 3602
2018
Q4
$2.02M Sell
1,744,745
-818,564
-32% -$1.87M ﹤0.01% 3661
2018
Q3
$9.48M Buy
2,563,309
+14,248
+0.6% +$45K ﹤0.01% 3255
2018
Q2
$7.8M Sell
2,549,061
-36,454
-1% -$135K ﹤0.01% 3349
2018
Q1
$10.1M Sell
2,585,515
-126,134
-5% -$553K ﹤0.01% 3128
2017
Q4
$12.2M Sell
2,711,649
-88,837
-3% -$421K ﹤0.01% 3046
2017
Q3
$15.3M Buy
2,800,486
+42,061
+2% +$259K ﹤0.01% 2936
2017
Q2
$20.9M Buy
2,758,425
+686,208
+33% +$2.96M ﹤0.01% 2763
2017
Q1
$7.36M Buy
2,072,217
+2,069,746
+83,761% +$10.2M ﹤0.01% 3242
2016
Q4
$14K Hold
2,471
﹤0.01% 3331
2016
Q3
$19K Hold
2,471
﹤0.01% 3298
2016
Q2
$15K Buy
2,471
+2,360
+2,126% +$18.3K ﹤0.01% 3330
2016
Q1
$1K Buy
+111
New +$1.05K ﹤0.01% 3529

Other funds holding IBRX